Tungstate Treatment of Inflammatory Bowel Disease-Associated Dysbiosis

Conditions of intestinal inflammation, from disease states such as inflammatory bowel disease, can lead to microbial imbalance (dysbiosis) characterized by the representation of microbes that are otherwise not found in the intestine, such as E. coli. This increased relative abundance of facultative anaerobic bacteria, such as E. coli is thought to exacerbate inflammatory bowel disease symptoms and duration. Researchers at the University of California, Davis have found that oral treatment of tungstate is an effective treatment of IBD. Administration of Tungstate diminished the total number of E. coli strains and allowed both facultative and obligate anaerobe strains to recover to similar levels, which indicated that tungsten blunts the fitness advantage conferred by anaerobic respiration as tungstate substitutes as a competitive antagonist for molybdenum in molybdopeterin cofactor of reductases used by E. coli to perform anaerobic respiration. These results suggest that oral administration of soluble tungsten salts can aid in restoring a normal micrbiota composition by specifically inhibiting anaerobic respiratory pathways operational only during gut inflammation. Treatment with tungsten salts has further been shown to reduce morbidity in mouse models of IBD. Researchers at the University of California, Davis have found that oral treatment of tungstate is an effective treatment of Inflammatory bowel disease.

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More